ATORX — Alligator Bioscience AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK670.76m
- SEK620.74m
- SEK58.11m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 197 | 103 | 278 | 97.3 | 66.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.08 | 4.92 | 14.5 | 17.6 | 4.52 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 206 | 110 | 300 | 123 | 78.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 33.5 | 23.2 | 15.4 | 26.9 | 20.3 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 311 | 152 | 333 | 170 | 118 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 40.9 | 30.7 | 47.4 | 64.5 | 99.1 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 52.6 | 36.7 | 50.9 | 80.5 | 107 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 258 | 115 | 282 | 89.1 | 11.9 |
Total Liabilities & Shareholders' Equity | 311 | 152 | 333 | 170 | 118 |
Total Common Shares Outstanding |